Author: philip onyeaka

23 Jan

Generic Drug Recalls and Safety Alerts: What Triggers a Recall

by philip onyeaka Jan 23 2026 2 Medications

Generic drug recalls happen due to manufacturing flaws like contamination, labeling errors, or potency issues. Learn what triggers a recall, how the FDA classifies risks, and what you should do if your medication is affected.

22 Jan

Narrow Therapeutic Index Drugs: What Patients Need to Know

by philip onyeaka Jan 22 2026 2 Medications

Narrow therapeutic index drugs require precise dosing-small changes can cause serious harm. Learn how to safely manage medications like warfarin, lithium, and levothyroxine with regular monitoring and consistent use.

21 Jan

How to Use Drug Interaction Checkers: Step-by-Step Guide

by philip onyeaka Jan 21 2026 5 Medications

Learn how to use drug interaction checkers safely and effectively to avoid dangerous medication combinations. Step-by-step guide for patients, caregivers, and anyone taking multiple drugs.

18 Jan

Low-Dose CT for Lung Screening: Who Qualifies and What to Expect

by philip onyeaka Jan 18 2026 6 Respiratory Health

Low-dose CT lung screening saves lives by catching cancer early. Learn who qualifies, what results mean, and why so few eligible people get tested-even though it's free and proven to cut deaths by 20%.

17 Jan

Medications That Are High-Risk for Seniors: What to Review

by philip onyeaka Jan 17 2026 8 Medications

Many common medications pose serious risks to seniors, including sleep aids, diabetes drugs, and antihistamines. Learn which ones to review, safer alternatives, and how to prevent dangerous side effects using the Beers Criteria.

16 Jan

How to Prioritize Replacements for Expired Critical Medications

by philip onyeaka Jan 16 2026 7 Medications

Learn how to safely prioritize replacements for expired critical medications using evidence-based protocols, tiered alternatives, and pharmacist-led systems to prevent patient harm and medication errors.

15 Jan

Pioglitazone Safety: What You Need to Know About Heart Failure, Edema, and Bladder Risks

by philip onyeaka Jan 15 2026 13 Medications

Pioglitazone lowers blood sugar but carries serious risks: heart failure, fluid retention, and possible bladder cancer. Learn who should avoid it, what symptoms to watch for, and safer alternatives available today.

14 Jan

Insurance Prior Authorization for Generic Alternatives: Navigating Policies in Pharmacy Practice

by philip onyeaka Jan 14 2026 11 Medications

Prior authorization for generic alternatives is a costly, time-consuming hurdle in pharmacy practice. Learn how insurers enforce step therapy, why denials happen, and what strategies actually work to get patients their meds faster.

10 Jan

How to Work with Your Doctor to Deprescribe and Save Money on Medications

by philip onyeaka Jan 10 2026 13 Medications

Learn how to safely stop unnecessary medications with your doctor to cut prescription costs, reduce side effects, and avoid hospital visits. Real strategies, real savings.

9 Jan

Cost Comparison: Authorized Generics vs First-to-File Generics in the U.S. Drug Market

by philip onyeaka Jan 9 2026 13 Pharmacy Savings

Authorized generics and first-to-file generics both cut drug costs, but authorized generics drive deeper price drops during the critical 180-day exclusivity window. Learn how they compare and how to save more on prescriptions.

8 Jan

How to Identify a Legitimate Generic Drug at the Pharmacy

by philip onyeaka Jan 8 2026 8 Medications

Learn how to spot a legitimate generic drug at the pharmacy by checking labels, pill appearance, and pharmacy credentials. Avoid counterfeit medications with these simple verification steps backed by FDA guidelines.

3 Jan

Antitrust Issues in Generic Substitution: How Big Pharma Blocks Cheaper Drugs

by philip onyeaka Jan 3 2026 9 Pharmaceuticals

Big pharma is using legal tricks to block cheaper generic drugs from replacing expensive brand-name medicines. Learn how product hopping, REMS abuse, and court rulings are shaping the fight over drug prices and competition.